A phase I study of an MVA vaccine targeting p53 in cancer.
Vincent M. Chung
Research Funding - Novartis
Nicola Hardwick
No relevant relationships to disclose
Joshua D.I. Ellenhorn
No relevant relationships to disclose
Jonathan R. Espenschied
No relevant relationships to disclose
Dean Lim
No relevant relationships to disclose
Peiguo Chu
No relevant relationships to disclose
Dajun Qian
No relevant relationships to disclose
Joseph Kim
No relevant relationships to disclose
Joseph Chao
Research Funding - Cerulean Pharma
Marwan Fakih
No relevant relationships to disclose
Yun Yen
No relevant relationships to disclose
Don J. Diamond
No relevant relationships to disclose